Cover Image
Market Research Report

Orthopedic Biomaterials Market Report Suite for US 2017-2023 | MedSuite (Includes 10 Reports)

Published by iData Research Inc. Product code 601873
Published Content info 1036 Pages
Delivery time: 1-2 business days
Price
Back to Top
Orthopedic Biomaterials Market Report Suite for US 2017-2023 | MedSuite (Includes 10 Reports)
Published: February 1, 2017 Content info: 1036 Pages
Description

The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which is represented by allografts, demineralized bone matrix, and synthetic bone graft market. The report also includes orthopedic growth factors, cellular allografts, orthopedic cell therapy, hyaluronic acid viscosupplementation, orthopedic cartilage repair, and spinal machined bone allograft markets.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Orthopedic biomaterials are associated with high research and development (R&D) costs, which have subsequently led to premium pricing to recoup these initial costs. This is the case for competitors in the cellular allograft, cell therapy and growth factor segments of the U.S. orthopedic biomaterials market. In particular, orthopedic growth factors have had relatively high average selling prices (ASP) since their introduction to the market due to the high costs of recombinant growth factor technologies. The high R&D costs associated with the growth factor segment provide entry barriers against potential competitors. Currently there are only two growth factor BMP-2 products in the United States. Since they're both used in different indications, there is a lack of direct competition, allowing companies such as Medtronic to charge a premium for the Spine indication and recover the large initial costs associated with R&D. The commoditized nature in some parts of the market, such as the allograft and DBM segments, which is due to the lack of product differentiation, has limited growth. The market is being driven by more competitors venturing outside their traditional space to tap into the high growth segments where they can charge a premium. These segments may include the cell therapy and cellular allograft segments, both of which have relatively high ASP.

Table of Contents
Product Code: iDATA_USOB17_MS

Table of Contents

  • LIST OF FIGURES VIII
  • LIST OF CHARTS XIII
  • EXECUTIVE SUMMARY 18
  • U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 18
  • COMPETITIVE ANALYSIS 20
  • MARKET TRENDS 22
  • MARKET DEVELOPMENTS 24
  • PROCEDURE NUMBERS 25
  • PROCEDURE CODES INVESTIGATED 26
  • MARKETS INCLUDED 27
  • KEY REPORT UPDATES 28
  • VERSION HISTORY 28
  • RESEARCH METHODOLOGY 29
  • 1.1 RESEARCH SCOPE 29
  • 1.2 IDATA'S 9-STEP METHODOLOGY 29
  • Step 1: Project Initiation & Team Selection 29
  • Step 2: Prepare Data Systems and Perform Secondary Research 31
  • Step 3: Preparation for Interviews & Questionnaire Design 32
  • Step 4: Performing Primary Research 33
  • Step 5: Research Analysis: Establishing Baseline Estimates 35
  • Step 6: Market Forecast and Analysis 36
  • Step 7: Identify Strategic Opportunities 38
  • Step 8: Final Review and Market Release 39
  • Step 9: Customer Feedback and Market Monitoring 40
  • U.S. DIAGNOSTIC OPHTHALMIC DEVICE MARKET OVERVIEW 41
  • 2.1 INTRODUCTION 41
  • 2.1.1 Bone Graft Substitutes 41
  • 2.1.2 Growth Factors 41
  • 2.1.3 Orthopedic Stem Cell Therapy 41
  • 2.1.4 Cell Therapies 41
  • 2.1.5 Hyaluronic Acid Viscosupplementation 41
  • 2.1.6 Cartilage Repair 41
  • 2.1.7 Spinal Machined Bone Allografts 41
  • 2.2 MARKET OVERVIEW 43
  • 2.3 TREND ANALYSIS BY SEGMENT 47
  • 2.4 DRIVERS AND LIMITERS 50
  • 2.4.1 Market Drivers 50
  • 2.4.2 Market Limiters 50
  • 2.5 COMPETITIVE MARKET SHARE ANALYSIS 52
  • 2.6 HERFINDAHL INDEX 55
  • PROCEDURE NUMBERS 56
  • 3.1 PROCEDURE DEFINITIONS 56
  • 3.2 BONE GRAFT PROCEDURE NUMBERS BY TYPE 57
  • 3.3 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 60
  • 3.3.1 By Material 60
  • 3.3.2 By Indication 63
  • 3.4 GROWTH FACTOR BONE GRAFT PROCEDURE NUMBERS 67
  • 3.5 STEM CELL BONE GRAFT PROCEDURE NUMBERS 69
  • 3.6 CELL THERAPY TREATMENT NUMBERS 71
  • 3.6.1 Overview by Type 71
  • 3.6.2 Platelet-Rich Treatment Numbers by Indication 73
  • 3.6.3 Platelet-Rich Treatment Numbers by Indication 76
  • 3.7 HYALURONIC ACID TREATMENT NUMBERS BY TYPE 79
  • 3.8 CARTILAGE REPAIR PROCEDURE NUMBERS BY TYPE 82
  • 3.9 SPINAL MACHINED BONE ALLOGRAFT PROCEDURE NUMBERS BY APPROACH 85
  • ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 88
  • 4.1 INTRODUCTION 88
  • 4.1.1 Units Per Procedure by Indication 89
  • 4.2 MARKET OVERVIEW 90
  • 4.2.1 Bone Graft Substitute Market by Material 90
  • 4.2.2 Bone Graft Substitute Market by Indication 94
  • 4.3 MARKET ANALYSIS AND FORECAST 98
  • 4.3.1 Total Orthopedic Bone Graft Substitute Market 98
  • 4.3.2 Bone Graft Substitute Market by Material 100
  • 4.3.2.1 Total Allograft Bone Graft Substitute Market 100
  • 4.3.2.2 Allograft Bone Graft Substitute Market by Indication 102
  • 4.3.2.2.1 Spine 104
  • 4.3.2.2.2 Trauma 110
  • 4.3.2.2.3 Large Joint Reconstruction 116
  • 4.3.2.2.4 Foot Reconstruction 122
  • 4.3.2.2.5 Craniomaxillofacial 124
  • 4.3.2.2.6 Oncology 126
  • 4.3.2.3 Total Demineralized Bone Matrix Market 128
  • 4.3.2.4 Demineralized Bone Matrix Market with and without Carriers 130
  • 4.3.2.5 Demineralized Bone Matrix Market by Indication 131
  • 4.3.2.5.1 Spine 133
  • 4.3.2.5.2 Trauma 139
  • 4.3.2.5.3 Large Joint Reconstruction 145
  • 4.3.2.5.4 Foot Reconstruction 151
  • 4.3.2.5.5 Craniomaxillofacial 153
  • 4.3.2.5.6 Oncology 155
  • 4.3.2.6 Total Synthetic Bone Graft Substitute Market 157
  • 4.3.2.7 Synthetic Bone Graft Substitute Market by Indication 159
  • 4.3.2.7.1 Spine 161
  • 4.3.2.7.2 Trauma 167
  • 4.3.2.7.3 Large Joint Reconstruction 173
  • 4.3.2.7.4 Foot Reconstruction 179
  • 4.3.2.7.5 Craniomaxillofacial 181
  • 4.3.2.7.6 Oncology 183
  • 4.3.3 Bone Graft Substitute Market by Indication 185
  • 4.3.3.1 Spine 185
  • 4.3.3.1.1 Cervical Spine 187
  • 4.3.3.1.2 Thoracolumbar Spine 189
  • 4.3.3.2 Trauma 191
  • 4.3.3.2.1 Non-Union Trauma 193
  • 4.3.3.2.2 Fresh Fracture Trauma 195
  • 4.3.3.3 Large Joint Reconstruction 197
  • 4.3.3.3.1 Hip Large Joint Reconstruction 199
  • 4.3.3.3.2 Knee Large Joint Reconstruction 201
  • 4.3.3.4 Foot Reconstruction 203
  • 4.3.3.5 Craniomaxillofacial 205
  • 4.3.3.6 Oncology 207
  • 4.4 DRIVERS AND LIMITERS 209
  • 4.4.1 Market Drivers 209
  • 4.4.2 Market Limiters 209
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 210
  • ORTHOPEDIC GROWTH FACTOR MARKET 213
  • 5.1 INTRODUCTION 213
  • 5.2 MARKET ANALYSIS AND FORECAST 214
  • 5.3 DRIVERS AND LIMITERS 216
  • 5.3.1 Market Drivers 216
  • 5.3.2 Market Limiters 216
  • 5.4 COMPETITIVE MARKET SHARE ANALYSIS 217
  • ORTHOPEDIC STEM CELL MARKET MARKET 220
  • 6.1 INTRODUCTION 220
  • 6.2 MARKET OVERVIEW 221
  • 6.3 MARKET ANALYSIS AND FORECAST 225
  • 6.3.1 Total Orthopedic Stem Cell Market 225
  • 6.3.1.1 Cervical Spine Stem Cell Market 227
  • 6.3.1.2 Lumbar Spine Stem Cell Market 229
  • 6.4 DRIVERS AND LIMITERS 231
  • 6.4.1 Market Drivers 231
  • 6.4.2 Market Limiters 231
  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS 232
  • ORTHOPEDIC CELL THERAPY MARKET 235
  • 7.1 INTRODUCTION 235
  • 7.2 MARKET OVERVIEW 236
  • 7.3 MARKET ANALYSIS AND FORECAST 240
  • 7.3.1 Total Platelet-Rich Plasma Market 240
  • 7.3.1.1 Soft Tissue Platelet-Rich Plasma Market 242
  • 7.3.1.2 Orthopedic Platelet-Rich Plasma Market 244
  • 7.3.1.3 Cardiac Platelet-Rich Plasma Market 246
  • 7.3.1.4 Spine Platelet-Rich Plasma Market 248
  • 7.3.1.5 Plastics Platelet-Rich Plasma Market 250
  • 7.3.2 Total Bone Marrow Concentrate Market 252
  • 7.3.2.1 Spine Bone Marrow Concentrate Market 254
  • 7.3.2.2 Trauma Bone Marrow Concentrate Market 256
  • 7.3.2.3 Soft Tissue Concentrated Bone Marrow Aspirate Market 258
  • 7.3.2.4 Joint Concentration Bone Marrow Concentrate Market 260
  • 7.4 DRIVERS AND LIMITERS 262
  • 7.4.1 Market Drivers 262
  • 7.4.2 Market Limiters 262
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 263
  • ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 266
  • 8.1 INTRODUCTION 266
  • 8.2 MARKET OVERVIEW 267
  • 8.3 MARKET ANALYSIS AND FORECAST 271
  • 8.3.1 Total Hyaluronic Acid Viscosupplementation Market 271
  • 8.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market 273
  • 8.3.1.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 275
  • 8.3.1.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 277
  • 8.4 DRIVERS AND LIMITERS 279
  • 8.4.1 Market Drivers 279
  • 8.4.2 Market Limiters 279
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 280
  • ORTHOPEDIC CARTILAGE REPAIR MARKET 283
  • 9.1 INTRODUCTION 283
  • 9.2 MARKET OVERVIEW 284
  • 9.3 MARKET ANALYSIS AND FORECAST 288
  • 9.3.1 Osteochondral Allograft Market 288
  • 9.3.2 Meniscal Allograft Market 290
  • 9.3.3 Autologous Chondrocyte Implantation Market 292
  • 9.3.4 Particulated Juvenile Allograft Implant Market 294
  • 9.3.5 Microfracture Adjunct Market 296
  • 9.4 DRIVERS AND LIMITERS 298
  • 9.4.1 Market Drivers 298
  • 9.4.2 Market Limiters 298
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 299
  • SPINAL MACHINED BONE ALLOGRAFT MARKET 302
  • 10.1 INTRODUCTION 302
  • 10.2 MARKET OVERVIEW 303
  • 10.3 MARKET ANALYSIS AND FORECAST 307
  • 10.3.1 Total Spinal Machined Bone Allograft Market 307
  • 10.3.2 ALIF Machined Bone Allograft Market 309
  • 10.3.2.1 PLIF Machined Bone Allograft Market 311
  • 10.3.2.2 TLIF Machined Bone Allograft Market 313
  • 10.3.2.3 CIF Machined Bone Allograft Market 315
  • 10.4 DRIVERS AND LIMITERS 317
  • 10.4.1 Market Drivers 317
  • 10.4.2 Market Limiters 317
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 318
  • ABBREVIATIONS 321

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023 19
  • Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2013 & 2023 19
  • Chart 2 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023 45
  • Chart 2 2: Orthopedic Biomaterials Market Breakdown, U.S., 2016 46
  • Chart 2 3: Orthopedic Biomaterials Market Breakdown, U.S., 2023 46
  • Chart 2 4: Growth Rates by Segment, Orthopedic Biomaterials Market, U.S., 2013 - 2023 49
  • Chart 2 5: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 54
  • Chart 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 - 2023 59
  • Chart 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 - 2023 62
  • Chart 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 66
  • Chart 3 4: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 - 2023 68
  • Chart 3 5: Stem Cell Bone Graft Procedure Numbers, U.S., 2013 - 2023 70
  • Chart 3 6: Cell Therapy Treatment Numbers by Type, U.S., 2013 - 2023 72
  • Chart 3 7: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 - 2023 75
  • Chart 3 8: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 - 2023 78
  • Chart 3 9: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 - 2023 81
  • Chart 3 10: Cartilage Repair Procedure Numbers by Type, U.S., 2013 - 2023 84
  • Chart 3 11: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 - 2023 87
  • Chart 4 1: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 - 2023 92
  • Chart 4 2: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2016 93
  • Chart 4 3: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2023 93
  • Chart 4 4: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 96
  • Chart 4 5: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2016 97
  • Chart 4 6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2023 97
  • Chart 4 7: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023 99
  • Chart 4 8: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 101
  • Chart 4 9: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 103
  • Chart 4 10: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 105
  • Chart 4 11: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023 107
  • Chart 4 12: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 109
  • Chart 4 13: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 111
  • Chart 4 14: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 113
  • Chart 4 15: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 115
  • Chart 4 16: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 117
  • Chart 4 17: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 119
  • Chart 4 18: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 121
  • Chart 4 19: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 123
  • Chart 4 20: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 125
  • Chart 4 21: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 127
  • Chart 4 22: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023 129
  • Chart 4 23: Demineralized Bone Matrix Market by Indication, U.S., 2013 - 2023 132
  • Chart 4 24: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 134
  • Chart 4 25: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 136
  • Chart 4 26: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 138
  • Chart 4 27: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 140
  • Chart 4 28: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 142
  • Chart 4 29: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 144
  • Chart 4 30: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 146
  • Chart 4 31: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 148
  • Chart 4 32: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 150
  • Chart 4 33: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 152
  • Chart 4 34: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023 154
  • Chart 4 35: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023 156
  • Chart 4 36: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023 158
  • Chart 4 37: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 160
  • Chart 4 38: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 162
  • Chart 4 39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 164
  • Chart 4 40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 166
  • Chart 4 41: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 168
  • Chart 4 42: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 170
  • Chart 4 43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 172
  • Chart 4 44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 174
  • Chart 4 45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 176
  • Chart 4 46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 178
  • Chart 4 47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 180
  • Chart 4 48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 182
  • Chart 4 49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 184
  • Chart 4 50: Spine Bone Graft Substitute Market, U.S., 2013 - 2023 186
  • Chart 4 51: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023 188
  • Chart 4 52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023 190
  • Chart 4 53: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 192
  • Chart 4 54: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 194
  • Chart 4 55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 196
  • Chart 4 56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 198
  • Chart 4 57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 200
  • Chart 4 58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 202
  • Chart 4 59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 204
  • Chart 4 60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023 206
  • Chart 4 61: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023 208
  • Chart 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016 212
  • Chart 5 1: Orthopedic Growth Factor Market, U.S., 2013 - 2023 215
  • Chart 5 2: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2016 219
  • Chart 6 1: Orthopedic Stem Cell Market by Segment, U.S., 2013 - 2023 223
  • Chart 6 2: Orthopedic Stem Cell Market Breakdown, U.S., 2016 224
  • Chart 6 3: Orthopedic Stem Cell Market Breakdown, U.S., 2023 224
  • Chart 6 4: Total Orthopedic Stem Cell Market, U.S., 2013 - 2023 226
  • Chart 6 5: Cervical Spine Stem Cell Market, U.S., 2013 - 2023 228
  • Chart 6 6: Lumbar Spine Stem Cell Market, U.S., 2013 - 2023 230
  • Chart 6 7: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016 234
  • Chart 7 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 - 2023 238
  • Chart 7 2: Orthopedic Cell Therapy Market Breakdown, U.S., 2016 239
  • Chart 7 3: Orthopedic Cell Therapy Market Breakdown, U.S., 2023 239
  • Chart 7 4: Total Platelet-Rich Plasma Market, U.S., 2013 - 2023 241
  • Chart 7 5: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 - 2023 243
  • Chart 7 6: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 - 2023 245
  • Chart 7 7: Cardiac Platelet-Rich Plasma Market, U.S., 2013 - 2023 247
  • Chart 7 8: Spine Platelet-Rich Plasma Market, U.S., 2013 - 2023 249
  • Chart 7 9: Plastics Platelet-Rich Plasma Market, U.S., 2013 - 2023 251
  • Chart 7 10: Total Bone Marrow Concentrate Market, U.S., 2013 - 2023 253
  • Chart 7 11: Spine Bone Marrow Concentrate Market, U.S., 2013 - 2023 255
  • Chart 7 12: Trauma Bone Marrow Concentrate Market, U.S., 2013 - 2023 257
  • Chart 7 13: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 - 2023 259
  • Chart 7 14: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 - 2023 261
  • Chart 7 15: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016 265
  • Chart 8 1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 - 2023 269
  • Chart 8 2: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2016 270
  • Chart 8 3: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2023 270
  • Chart 8 4: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 272
  • Chart 8 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 274
  • Chart 8 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 276
  • Chart 8 7: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 278
  • Chart 8 8: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016 282
  • Chart 9 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2013 - 2023 286
  • Chart 9 2: Orthopedic Cartilage Repair Market Breakdown, U.S., 2016 287
  • Chart 9 3: Orthopedic Cartilage Repair Market Breakdown, U.S., 2023 287
  • Chart 9 4: Osteochondral Allograft Market, U.S., 2013 - 2023 289
  • Chart 9 5: Meniscal Allograft Market, U.S., 2013 - 2023 291
  • Chart 9 6: Autologous Chondrocyte Implantation Market, U.S., 2013 - 2023 293
  • Chart 9 7: Particulated Juvenile Allograft Implant Market, U.S., 2013 - 2023 295
  • Chart 9 8: Microfracture Adjunct Market, U.S., 2013 - 2023 297
  • Chart 9 9: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2016 301
  • Chart 10 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 - 2023 305
  • Chart 10 2: Spinal Machined Bone Allograft Market Breakdown, U.S., 2016 306
  • Chart 10 3: Spinal Machined Bone Allograft Market Breakdown, U.S., 2023 306
  • Chart 10 4: Total Spinal Machined Bone Allograft Market, U.S., 2013 - 2023 308
  • Chart 10 5: ALIF Machined Bone Allograft Market, U.S., 2013 - 2023 310
  • Chart 10 6: PLIF Machined Bone Allograft Market, U.S., 2013 - 2023 312
  • Chart 10 7: TLIF Machined Bone Allograft Market, U.S., 2013 - 2023 314
  • Chart 10 8: CIF Machined Bone Allograft Market, U.S., 2013 - 2023 316
  • Chart 10 9: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016 320

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2) 20
  • Figure 1 2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2) 20
  • Figure 1 3: Companies Researched in this Report, U.S., 2016 21
  • Figure 1 4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2) 22
  • Figure 1 5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2) 23
  • Figure 1 6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 - 2016 24
  • Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 25
  • Figure 1 8: Procedure Codes Investigated, U.S., 2016 26
  • Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016 27
  • Figure 1 10: Key Report Updates 28
  • Figure 1 11: Version History 28
  • Figure 2 1: Total Orthopedic Biomaterials Market, U.S., 2013 - 2023 (US$M) 43
  • Figure 2 2: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023 (US$M) (1 of 2) 44
  • Figure 2 3: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023 (US$M) (2 of 2) 44
  • Figure 2 4: Orthopedic Biomaterials Market Growth by Segment, U.S., 2013 - 2023 48
  • Figure 2 5: Drivers and Limiters, Orthopedic Biomaterials Market, U.S., 2016 51
  • Figure 2 6: Leading Competitors, Orthopedic Biomaterials Market, U.S., 2016 53
  • Figure 2 7: Herfindahl Index, Orthopedic Biomaterials Market, U.S., 2016 55
  • Figure 3 1: Bone Graft Procedure Numbers by Type, U.S., 2013 - 2023 58
  • Figure 3 2: Bone Graft Substitute Procedure Numbers by Material, U.S., 2013 - 2023 61
  • Figure 3 3: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 (1 of 2) 64
  • Figure 3 4: Bone Graft Substitute Procedure Numbers by Indication, U.S., 2013 - 2023 (2 of 2) 65
  • Figure 3 5: Growth Factor Bone Graft Procedure Numbers, U.S., 2013 - 2023 67
  • Figure 3 6: Stem Cell Bone Graft Procedure Numbers, U.S., 2013 - 2023 69
  • Figure 3 7: Cell Therapy Treatment Numbers by Type, U.S., 2013 - 2023 71
  • Figure 3 8: Platelet-Rich Plasma Treatment Numbers by Indication, U.S., 2013 - 2023 74
  • Figure 3 9: Bone Marrow Concentrate Treatment Numbers by Indication, U.S., 2013 - 2023 77
  • Figure 3 10: Hyaluronic Acid Treatment Numbers by Type, U.S., 2013 - 2023 80
  • Figure 3 11: Cartilage Repair Procedure Numbers by Type, U.S., 2013 - 2023 83
  • Figure 3 12: Spinal Machined Bone Allograft Procedure Numbers by Approach, U.S., 2013 - 2023 86
  • Figure 4 1: Units per Procedure by Indication, Bone Graft Substitute Market, U.S., 2011 - 2021 89
  • Figure 4 2: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 - 2023 (US$M) 91
  • Figure 4 3: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 (US$M) 95
  • Figure 4 4: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023 98
  • Figure 4 5: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 100
  • Figure 4 6: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 102
  • Figure 4 7: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 104
  • Figure 4 8: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 106
  • Figure 4 9: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 108
  • Figure 4 10: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 110
  • Figure 4 11: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 112
  • Figure 4 12: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 114
  • Figure 4 13: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 116
  • Figure 4 14: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 118
  • Figure 4 15: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 120
  • Figure 4 16: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 122
  • Figure 4 17: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 124
  • Figure 4 18: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023 126
  • Figure 4 19: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023 128
  • Figure 4 20: Demineralized Bone Matrix Market (with Carriers), U.S., 2013 - 2023 130
  • Figure 4 21: Demineralized Bone Matrix Market (without Carriers), U.S., 2013 - 2023 130
  • Figure 4 22: Demineralized Bone Matrix Market by Indication, U.S., 2013 - 2023 131
  • Figure 4 23: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 133
  • Figure 4 24: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 135
  • Figure 4 25: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023 137
  • Figure 4 26: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 139
  • Figure 4 27: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 141
  • Figure 4 28: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023 143
  • Figure 4 29: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 145
  • Figure 4 30: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 147
  • Figure 4 31: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 149
  • Figure 4 32: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023 151
  • Figure 4 33: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023 153
  • Figure 4 34: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023 155
  • Figure 4 35: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023 157
  • Figure 4 36: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 159
  • Figure 4 37: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 161
  • Figure 4 38: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 163
  • Figure 4 39: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 165
  • Figure 4 40: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 167
  • Figure 4 41: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 169
  • Figure 4 42: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 171
  • Figure 4 43: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 173
  • Figure 4 44: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 175
  • Figure 4 45: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 177
  • Figure 4 46: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 179
  • Figure 4 47: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 181
  • Figure 4 48: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023 183
  • Figure 4 49: Spine Bone Graft Substitute Market, U.S., 2013 - 2023 185
  • Figure 4 50: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023 187
  • Figure 4 51: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023 189
  • Figure 4 52: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 191
  • Figure 4 53: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 193
  • Figure 4 54: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023 195
  • Figure 4 55: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 197
  • Figure 4 56: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 199
  • Figure 4 57: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 201
  • Figure 4 58: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023 203
  • Figure 4 59: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023 205
  • Figure 4 60: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023 207
  • Figure 4 61: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2016 209
  • Figure 4 62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016 211
  • Figure 5 1: Orthopedic Growth Factor Market, U.S., 2013 - 2023 214
  • Figure 5 2: Drivers and Limiters, Orthopedic Growth Factor Market, U.S., 2016 216
  • Figure 5 3: Leading Competitors, Orthopedic Growth Factor Market, U.S., 2016 218
  • Figure 6 1: Orthopedic Stem Cell Market by Segment, U.S., 2013 - 2023 (US$M) 222
  • Figure 6 2: Total Orthopedic Stem Cell Market, U.S., 2013 - 2023 225
  • Figure 6 3: Cervical Spine Stem Cell Market, U.S., 2013 - 2023 227
  • Figure 6 4: Lumbar Spine Stem Cell Market, U.S., 2013 - 2023 229
  • Figure 6 5: Drivers and Limiters, Orthopedic Stem Cell Market, U.S., 2016 231
  • Figure 6 6: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016 233
  • Figure 7 1: Orthopedic Cell Therapy Market by Segment, U.S., 2013 - 2023 (US$M) 237
  • Figure 7 2: Total Platelet-Rich Plasma Market, U.S., 2013 - 2023 240
  • Figure 7 3: Soft Tissue Platelet-Rich Plasma Market, U.S., 2013 - 2023 242
  • Figure 7 4: Orthopedic Platelet-Rich Plasma Market, U.S., 2013 - 2023 244
  • Figure 7 5: Cardiac Platelet-Rich Plasma Market, U.S., 2013 - 2023 246
  • Figure 7 6: Spine Platelet-Rich Plasma Market, U.S., 2013 - 2023 248
  • Figure 7 7: Plastics Platelet-Rich Plasma Market, U.S., 2013 - 2023 250
  • Figure 7 8: Total Bone Marrow Concentrate Market, U.S., 2013 - 2023 252
  • Figure 7 9: Spine Bone Marrow Concentrate Market, U.S., 2013 - 2023 254
  • Figure 7 10: Trauma Bone Marrow Concentrate Market, U.S., 2013 - 2023 256
  • Figure 7 11: Soft Tissue Concentrated Bone Marrow Aspirate Market, U.S., 2013 - 2023 258
  • Figure 7 12: Joint Concentration Bone Marrow Concentrate Market, U.S., 2013 - 2023 260
  • Figure 7 13: Drivers and Limiters, Orthopedic Cell Therapy Market, U.S., 2016 262
  • Figure 7 14: Leading Competitors, Orthopedic Cell Therapy Market, U.S., 2016 264
  • Figure 8 1: Orthopedic Hyaluronic Acid Viscosupplementation Market by Segment, U.S., 2013 - 2023 (US$M) 268
  • Figure 8 2: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 271
  • Figure 8 3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 273
  • Figure 8 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 275
  • Figure 8 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023 277
  • Figure 8 6: Drivers and Limiters, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016 279
  • Figure 8 7: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016 281
  • Figure 9 1: Orthopedic Cartilage Repair Market by Segment, U.S., 2013 - 2023 (US$M) 285
  • Figure 9 2: Osteochondral Allograft Market, U.S., 2013 - 2023 288
  • Figure 9 3: Meniscal Allograft Market, U.S., 2013 - 2023 290
  • Figure 9 4: Autologous Chondrocyte Implantation Market, U.S., 2013 - 2023 292
  • Figure 9 5: Particulated Juvenile Allograft Implant Market, U.S., 2013 - 2023 294
  • Figure 9 6: Microfracture Adjunct Market, U.S., 2013 - 2023 296
  • Figure 9 7: Drivers and Limiters, Orthopedic Cartilage Repair Market, U.S., 2016 298
  • Figure 9 8: Leading Competitors, Orthopedic Cartilage Repair Market, U.S., 2016 300
  • Figure 10 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 - 2023 (US$M) 304
  • Figure 10 2: Total Spinal Machined Bone Allograft Market, U.S., 2013 - 2023 307
  • Figure 10 3: ALIF Machined Bone Allograft Market, U.S., 2013 - 2023 309
  • Figure 10 4: PLIF Machined Bone Allograft Market, U.S., 2013 - 2023 311
  • Figure 10 5: TLIF Machined Bone Allograft Market, U.S., 2013 - 2023 313
  • Figure 10 6: CIF Machined Bone Allograft Market, U.S., 2013 - 2023 315
  • Figure 10 7: Drivers and Limiters, Spinal Machined Bone Allograft Market, U.S., 2016 317
  • Figure 10 8: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016 319
Back to Top